subject area of
- A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: The IVORY trial Academic Article
- A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching. Academic Article
- Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice Academic Article
- Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting Academic Article
- Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained. Academic Article
- Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of High-Voltage Leads Academic Article
- Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions Academic Article
- Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis. Academic Article
- Comparative Tolerability of the Newer Fluoroquinolone Antibacterials Academic Article
- Coverage with evidence development: The Ontario experience Academic Article
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases Academic Article
- Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor Academic Article
- Fenoterol and fatal asthma Academic Article
- Final results from a postmarket registry of an iliac leg graft with a continuous, spiral nitinol stent Conference Paper
- Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach. Academic Article
- Gastrointestinal safety profile of nabumetone: a meta-analysis Academic Article
- How to Ascertain Drug Safety in the Context of Benefit. Controversies and Concerns: Table 1. Academic Article
- Insight into the mechanism of failure of the Riata lead under advisory Academic Article
- Is there really misuse and abuse of dabigatran? Academic Article
- Minimal dataset for post-registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH Academic Article
- NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank Academic Article
- NOACs for treatment of venous thromboembolism in clinical practice Academic Article
- New Orthopedic Devices and the FDA Academic Article
- Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference Academic Article
- Patient data meta‐analysis of Post‐Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated with rAHF ‐PFM Academic Article
- Procedures and methods of benefit assessments for medicines in Germany: give the child a name Academic Article
- Review and Analysis of the Effects of Olestra, a Dietary Fat Substitute, on Gastrointestinal Function and Symptoms Academic Article
- Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting Academic Article
- The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility? Academic Article
- The gastrointestinal tolerability and safety of oral bisphosphonates Academic Article